acamprosate
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for acamprosate, covering 2010-05-03 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) [Phase 1]